Vistin Pharma ASA (LON:0RAM)

Market Cap	74.73M
Revenue (ttm)	30.20M
Net Income (ttm)	4.41M
Shares Out	n/a
EPS (ttm)	0.10
PE Ratio	16.94
Forward PE	n/a
Dividend	0.07 (0.31%)
Ex-Dividend Date	Jun 4, 2025

Volume	21
Average Volume	1,055
Open	22.90
Previous Close	24.40
Day's Range	22.90 - 22.90
52-Week Range	1.62 - 1.94
Beta	1.03
RSI	49.66
Earnings Date	Feb 13, 2025

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1969
• Employees: 77
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RAM

Financial Performance

In 2024, Vistin Pharma ASA's revenue was 429.50 million, a decrease of -2.01% compared to the previous year's 438.33 million. Earnings were 62.75 million, an increase of 37.63%.

Financial numbers in NOK